Anti-vascular endothelial growth factor for neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Published:2019-03-04 Issue:3 Volume:2019 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Solomon Sharon D¹,Lindsley Kristina²,Vedula Satyanarayana S³,Krzystolik Magdalena G⁴,Hawkins Barbara S¹

Affiliation:

1. Johns Hopkins University School of Medicine; Wilmer Eye Institute; 600 North Wolfe Street Maumenee 740 Baltimore Maryland USA 21287

2. Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 North Wolfe Street, Mail Room E6132 Baltimore Maryland USA 21205

3. Johns Hopkins University; 3400 N. Charles Street Baltimore Maryland USA 21218

4. Mass Eye and Ear Infirmary; Department of Ophthalmology, Retina Service; 1 Randall Square, Suite 203 Providence Rhode Island USA 02904

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005139.pub4/epdf/full

Reference308 articles.

1. Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration;Keane;Investigative Ophthalmology and Visual Science,2012

2. Contrast sensitivity outcomes in the ABC Trial: a randomized trial of bevacizumab for neovascular age-related macular degeneration;Patel;Investigative Ophthalmology and Visual Science,2011

3. The ABC trial - a randomized double-masked phase III study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularization secondary to age-related macular degeneration (AMD);Patel;Investigative Ophthalmology and Visual Science,2007

4. Impact of anti-vascular endothelial growth factor therapy on reading performance in age-related macular degeneration: a randomized controlled trial;Patel;Investigative Ophthalmology and Visual Science,2015

5. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design;Patel;Trials,2008

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Personalized Medicine with Generative AI: A Systematic Review;2024-01-24

2. Age-Related Macular Degeneration;JAMA;2024-01-09

3. Intravitreal anti‐vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study;Acta Ophthalmologica;2023-12-09

4. Pathologic vs. protective roles of hypoxia-inducible factor 1 in RPE and photoreceptors in wet vs. dry age-related macular degeneration;Proceedings of the National Academy of Sciences;2023-12-06

5. Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: a systematic review and network meta-analysis;BMC Ophthalmology;2023-11-21